Newco Allecra debuts with EUR 15M

Allecra Therapeutics GmbH (Loerrach, Germany) debuted with EUR 15 million ($19.6 million) in a series A round co-led by Edmond de Rothschild and Forbion Capital Partners. EMBL Ventures also participated. Allecra is developing antibiotics to treat multi-drug resistant Gram-negative infections. The company plans to start Phase I testing of a compound this year, but declined to disclose details. ...